Next Article in Journal
Dielectric Spectroscopy to Improve the Production of rAAV Used in Gene Therapy
Next Article in Special Issue
Design and Construction of pH-Selective Self-Lytic Liposome System
Previous Article in Journal
Effect of Variety on Rehydration Characteristics of Dried Apples
Previous Article in Special Issue
Tandem-Homodimer of a β-Sheet-Forming Short Peptide Inhibits Random-to-β Structural Transition of Its Original Monomer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Processes
Volume 8
Issue 11
10.3390/pr8111455
processes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Horseradish Peroxidase-Decorated Artificial Viral Capsid Constructed from β-Annulus Peptide via Interaction between His-Tag and Ni-NTA

by
Kazunori Matsuura
1,2,*,
Yuriko Shiomi
1,
Toshihumi Mizuta
3 and
Hiroshi Inaba
1,2
1
Department of Chemistry and Biotechnology, Graduate School of Engineering, Tottori University, Tottori 680-8552, Japan
2
Centre for Research on Green Sustainable Chemistry, Tottori University, Tottori 680-8552, Japan
3
Technical Department, Tottori University, Tottori 680-8552, Japan
*
Author to whom correspondence should be addressed.
Processes 2020, 8(11), 1455; https://doi.org/10.3390/pr8111455
Submission received: 28 September 2020 / Revised: 7 November 2020 / Accepted: 12 November 2020 / Published: 13 November 2020
(This article belongs to the Special Issue Advances of Peptide Engineering)
Browse Figures
Versions Notes

Abstract

:
Artificial construction of spherical protein assemblies has attracted considerable attention due to its potential use in nanocontainers, nanocarriers, and nanoreactors. In this work, we demonstrate a novel strategy to construct peptide nanocapsules (artificial viral capsids) decorated with enzymes via interactions between His-tag and Ni-NTA. A β-annulus peptide derived from the tomato bushy stunt virus was modified with Ni-NTA at the C-terminus, which is directed toward the exterior surface of the artificial viral capsid. The β-annulus peptide bearing Ni-NTA at the C-terminus self-assembled into capsids of about 50 nm in diameter. The Ni-NTA-displayed capsids were complexed with recombinant horseradish peroxidase (HRP) with a C-terminal His-tag which was expressed in Escherichia coli. The β-annulus peptide-HRP complex formed spherical assemblies whose sizes were 30–90 nm, with the ζ-potential revealing that the HRP was decorated on the outer surface of the capsid.

Graphical Abstract

1. Introduction

Natural supramolecular protein nanocapsules such as viral capsids [1,2], clathrin [3], carboxysomes [4], encapsulins [5,6], lumazine synthases [7], and ferritins [8,9] play pivotal roles in many biological processes associated with compartments, transports, and reactions. Natural and engineered protein nanocapsules with a discrete size and hollow nanospace have been used as biomedical carriers and reactors for artificial nanomaterials [6,7,8,9,10,11,12,13,14,15]. Advances in the molecular design of proteins/peptides mimicking natural nanocapsules have made it possible to create nanocapsules with functions comparable to or surpassing those of natural ones [16,17,18,19,20,21,22]. One of the main strategies in constructing artificial protein/peptide nanocapusles is by self-assembly of amphiphilic molecules. For example, Nolte et al. demonstrated that protein nanocapsules can be self-assembled from “giant amphiphiles” consisting of horseradish peroxidase (HRP) and polystyrene, which are used in peroxidase-based enzymatic cascade reaction systems [23,24,25]. Hayashi et al. developed an artificial light-harvesting protein nanocapsule self-assembled from hexameric hemoproteins modified with poly(N-isopropylacrylamide) [26]. Another strategy to construct artificial nanocapsules is to utilize the interactions among secondary structures in the self-assembling protein/peptide subunits [27,28,29,30,31,32]. For example, Kawakami et al. designed polyhedral protein nanocapusles constructed from fusion proteins consisting of pentamer- and dimer-forming coiled-coil units [29]. Marsh and coworkers developed highly stable icosahedral protein nanocapsules self-assembled from trimeric protein subunits bearing rigid coiled-coils [30]. Although the construction strategy of artificial protein/peptide nanocapsules has progressed, the chemical functionalization of nanocapsules remains a challenge.
We have previously reported that a 24-mer β-annulus peptide derived from tomato bushy stunt virus capsid spontaneously formed hollow nanoassemblies, “artificial viral capsids” [33], which can encapsulate various guests such as anionic dyes, DNAs, quantum dots, and His-tagged proteins [19,34,35,36,37,38]. Furthermore, modification of the C-terminus, which is expected to be directed toward the exterior surface of the capsid, enabled modification of the outer surface of artificial viral capsids with gold nanoparticles, coiled-coil peptides, single-stranded DNAs, human serum albumin, and ribonuclease S [39,40,41,42,43,44]. These decorations onto artificial viral capsids were based on covalent bonds between β-annulus peptide and functional molecules or reconstruction of proteins. In this study, we developed a simple, general method to decorate proteins bearing tags onto the artificial viral capsids. That is, we constructed HRP-decorated artificial viral capsids via specific interactions between the His-tag connected to the C-terminus of HRP and Ni-NTA displayed on the capsid surface (Figure 1 and Figure 2).

2. Materials and Methods

2.1. General

Chemical reagents obtained from commercial sources were used without further purification. Ultrapure water (>18 MΩ cm) purified using a Millipore Purification System (Milli-Q water) was used as a solvent for the peptides. Reverse phase HPLC was performed at room temperature using a Shimadzu LC-6AD liquid chromatography system equipped with Inertsil WP300 C4 (GL Science) columns (250 × 4.6 mm or 250 × 20 mm) and a UV/Vis detector (220 nm, Shimadzu SPD-10AVvp). MALDI-TOF mass spectra were measured using an Autoflex T2 instrument (Bruker Daltonics) in linear/positive mode with a matrix (α-cyano-4-hydroxy cinnamic acid (α-CHCA) or sinapinic acid) circular dichroism (CD) spectra were measured using a JASCO J-820 spectrophotometer equipped with a Peltier-type thermostatic cell holder at 25 °C in a 1.0 mm quartz cell.

2.2. Preparetion of His-Tagged HRP

A nucleotide fragment of HRP was amplified using standard PCR methods. The HRP fragment was cloned into a pET23a vector, with its His-tag and additional sequence (AAALGHHHHHH) located at the C-terminus, using the In-Fusion cloning kit (TaKaRa Bio). The pET23a vector encoding His-tagged HRP was transformed into an Escherichia coli strain (BLR(DE3)). Bacterial cells were spread on Luria-Bertani (LB) agar containing 50 μg/mL ampicillin and grown at 37 °C overnight. A single transformant colony was grown in LB medium at 37 °C overnight. The culture was diluted 100-fold by the addition of fresh LB medium and grown to an optical density (OD) of 0.5, and the culture was subsequently incubated with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) at 37 °C. After incubation for 3 h, cells were harvested by centrifugation at 8000 rpm for 10 min. The cell pellets were suspended in buffer A (50 mM Tris-HCl pH 8.0, 1 mM ethylenediaminetetraacetic acid (EDTA), 10 mM dithiothreitol (DTT)). The cells were lysed by sonication. Three centrifugations at 14,500 rpm for 20 min were carried out. After the first centrifugation, the pellets were washed with buffer A supplemented with 2 M urea. After the second centrifugation, the inclusion body was solubilized in buffer B (50 mM Tris-HCl pH 8.0, 1 mM DTT, 6 M urea). After the third centrifugation, His-tagged apo-HRP in the supernatant was refolded according to reported procedures [45]. The refolded His-tagged HRP was purified by a HisTrap HP column (GE Healthcare) using an elution buffer (10 mM Tris-HCl pH 7.4, 0.15 M NaCl, 200 mM imidazole, 2M Urea). The His-tagged apo-HRP was characterized using SDS-PAGE and MALDI-TOF-MS. The eluted sample (0.4 mg/mL) was mixed with hemin (2 equivalents) in 10 mM Tris-HCl pH 7.2 and stirred for 40 min. The sample was dialyzed (1 kDa cut-off) against 10 mM Tris-HCl pH 7.2 overnight. The His-tag HRP obtained was characterized using MALDI-TOF-MS.

2.3. Preparation of β-Annulus Peptide C-Terminus-Modified with Ni-NTA

The β-annulus-GGGCG peptide H-Ile-Asn(Trt)-His(Trt)-Val-Gly-Gly-Thr(tBu)-Ile-Met-Ala- Pro-Val-Ala-Val-Thr(tBu)-Arg(Pbf)-Gln(Trt)-Leu-Val-Gly-Ser(tBu)-Gly-Gly-Gly-Cys(Trt)-Gly-Alko-PEG resin was synthesized using standard Fmoc-based coupling reactions (4 equivalents. Fmoc-amino acids) at a 0.125 mmol scale on commercially available Fmoc-Gly-Alko-PEG resin (0.22 mmol/g, Watanabe Chemical Ind. Ltd.). The deprotection of Fmoc groups was carried out with 20% piperidine in N,N-dimethylformamide (DMF) at room temperature for 15 min. Coupling reactions of the Fmoc-protected amino acids (4 equivalents) were carried out for 90 min at room temperature using four equivalents of (1-cyano-2-ethoxy-2-oxoethylidenaminooxy) dimethylamino-morpholino-carbenium hexafluorophosphate (COMU) in N-methylpyrrolidone (NMP) and eight equivalents of diisopropylamine (DIPEA) in NMP. Progression of the coupling reactions and deprotection of the Fmoc group was confirmed by a 2,4,6-trinitrobenzenesulfonic acid (TNBS) and chloranil test kit (Tokyo Chemical Industry Co., Ltd.). The peptidyl resin was washed with NMP. The peptide was cleaved from the resin and deprotected with a cleavage cocktail of trifluoroacetic acid (TFA)/1,2-ethanedithiol/triisopropylsilane/thioanisole/water [8.15/0.25/0.10/0.50/0.50 (mL),] at room temperature for 3 h. After filtration to remove resins, the filtrates were concentrated in vacuo. The peptide was precipitated with methyl tert-butyl ether and the supernatant was decanted. After three washes with methyl tert-butyl ether, the peptide was freeze-dried to give 228 mg of a colorless solid (66% yield). The reverse-phase HPLC of the crude peptide was eluted with a linear gradient of CH3CN/water containing 0.1% TFA (26/74 to 29/71 over 120 min) and showed one peak at 23 min. The isolated yield was 24%. MALDI-TOF MS (matrix: α-CHCA): m/z = 2637 [M]+.
A 1.0 mM aqueous solution of β-annulus-GGGCG peptide in 10 mM Tris-HCl buffer (pH 7.2, 0.1 mL) was mixed with a 2.5 mM aqueous solution (0.1 mL) of maleimido-C3-NTA (Dojindo Laboratories), and then the mixture was incubated for 15 h at room temperature. The mixture was purified using reversed-phase HPLC and eluted with a linear gradient of acetonitrile/water (26/74 to 29/71 over 120 min) containing 0.1% TFA to provide pure β-annulus-NTA peptide (isolated yield 42%). MALDI-TOF-MS (matrix: α-CHCA): m/z = 3064 [M]+.
The purified β-annulus-NTA peptide was dissolved in 10 mM Tris-HCl buffer to prepare a 5.0 mM aqueous solution. Subsequently, an aliquot of NiCl2 solution in 10 mM Tris-HCl buffer was added to the peptide solution to become [peptide] = [Ni2+] = 2.5 mM. Formation of the β-annulus-Ni-NTA complex was confirmed by MALDI-TOF-MS (matrix: α-CHCA): m/z = 3123 [M]+.

2.4. Complexation of His-Tagged HRP with Ni-NTA-Modified β-Annulus Peptide

Stock solutions (0.1 mM) of β-annulus-Ni-NTA were prepared by dissolution in 10 mM Tris-HCl buffer (pH 7.2). The complexes of β-annulus-Ni-NTA with His-tagged HRP were prepared by mixing with aqueous solutions of His-tagged HRP in the same buffer and then incubating at 25 °C for 24 h.

2.5. Dynamic Light Scattering (DLS) and ζ-Potential

DLS was measured using a Zetasizer Nano ZS (MALVERN) instrument with an incident He–Ne laser (633 nm) at 25 °C. G(τ) (correlation times of the scattered light intensities) were measured several times and then the diffusion coefficient were calculated from the mean values of G(τ). Using the Stokes–Einstein equation, hydrodynamic diameters of the scattering particles were calculated. Zeta potentials of β-annulus-Ni-NTA, His-tagged HRP, and their mixture at 25 μM in 10 mM Tris-HCl buffer (pH 7.2) were measured at 25 °C using the same instrument with a DT1061 clear disposable zeta cell.

2.6. Transmission Electron Microscopy (TEM)

Aliquots (3 μL) of the samples were applied to C-SMART Hydrophilic TEM grids(ALLIANCE Biosystems Inc) for one min. Then, the droplet was removed using filter paper. Subsequently, the TEM grids were placed into a staining aqueous solution, 2% phosphotungstic acid [Na3(PW12O40) (H2O)n] (3 μL), for one min, and then removed. After the sample-loaded TEM grids were dried in vacuo, they were observed using TEM (JEOL JEM 1400 Plus) using 80 kV accelerating voltage.

2.7. HRP Activity

The specific HRP activity was evaluated by a method adapted from the literature [46]. A solution (350 μL) of 4-aminoantipyrine (25 mM) and phenol (17 mM) in 0.2 M potassium phosphate buffer (pH 7.0) and an aqueous solution (375 μL) of hydrogen peroxide (17 mM) in Milli-Q water was added to a quartz cell (path length: 1 cm). After incubation for 4 min at 25 °C, the HRP-decorated artificial viral capsid was added to the quartz cell (final concentration of HRP: 25 μM). The absorbance change was measured at 510 nm over 250 s. The specific enzyme activity was calculated from the slope of the absorbance change divided by the concentration of protein in mg/mL.

3. Results

3.1. Construction of an Artificial Viral Capsid Modified with Ni-NTA at the Surface

To construct an artificial viral capsid modified with Ni-NTA at the surface, we designed a Cys-containing β-annulus peptide at the C-terminal side (β-annulus-GGGCG peptide) which was directed toward the exterior of the capsid [34,39,42]. The β-annulus-GGGCG peptide (INHVGGTGGAIMAPVAVTRQLVGSGGGCG) was synthesized by standard Fmoc-protected solid-phase method, purified by reversed-phase HPLC, and confirmed by MALDI-TOF-MS (m/z = 2637). The Cys of the peptide was reacted with maleimido-C3-NTA to obtain β-annulus peptide modified with NTA at the C-terminus. After the β-annulus-NTA peptide was purified by reversed-phase HPLC and analyzed by MALDI-TOF-MS (m/z = 3064), the peptide was complexed with NiCl2 to obtain β-annulus-Ni-NTA peptide, which was analyzed by MALDI-TOF-MS (m/z = 3123).
Size distribution obtained from DLS and TEM images of the solutions of the β-annulus-Ni-NTA peptide in 10 mM Tris-HCl buffer (pH 7.2) revealed the formation of spherical assemblies of approximately 50 nm in diameter (Figure 3). The diameter is comparable to the diameter of unmodified [33] and modified artificial viral capsids [35,38,39,40,41,42,43] self-assembled from β-annulus peptide derivatives, which indicates that Ni-NTA modification of the β-annulus peptide at the C-terminus minimally affected the self-assembling behavior. The relatively broad size distribution observed by DLS of 25 μM Ni-NTA-modified β-annulus peptide might be caused by relatively unstable assembly of the peptide with dynamic equilibrium at a lower concentration. The concentration dependence on the scattering intensity obtained from DLS showed that the critical aggregation concentration (CAC) of the C-terminus-Ni-NTA modified β-annulus peptide in a Tris-HCl buffer at 25 °C was approximately 10 μM (Figure 4), which is comparable to the CAC of an unmodified β-annulus peptide (25 μM) [33], but higher than that of the N-terminus-Ni-NTA modified β-annulus peptide (0.053 μM) [38].

3.2. Preparation of His-Tagged HRP

Recombinant horseradish peroxidase with a C-terminal His6 tag (His-tagged HRP, Figure 2) was expressed from the pET23a vector encoding His-tagged HRP in an E. coli BLR (DE3) expression system as reported in the literature (Figure 5) [45]. For protein expression and purification, the transformants were cultured in LB media, and expression of the plasmid was induced by IPTG. After the disruption of cells by sonication, the inclusion body was solubilized in a buffer containing 6 M urea. The refolded His-tagged apo-HRP was purified by a Ni-NTA column eluted with imidazole. The SDS-PAGE revealed the formation and isolation of 32 kDa His-tagged apo-HRP (Figure 6a). His-tagged HRP was formed by reconstruction of His-tagged apo-HRP with hemin and confirmed by MALDI-TOF-MS (Figure 6b). The theoretical molecular mass of His-tagged HRP reconstructed with hemin is calculated to be 35,768 Da based on the amino acids sequence. Considering the broad peak (35,029 Da) observed by MALDI-TOF-MS, we decided that the mass was almost comparable to the theoretical value. The UV-vis spectrum of hemin was red-shifted by reconstruction to produce a spectrum similar to commercially available HRP (Figure 7), indicating a successful reconstruction of His-tagged HRP. The slight difference of maximum absorption wavelength of His-tagged HRP (410 nm) and commercially available HRP (403 nm) might be caused by difference of environment around hemin in HRP.

3.3. Construction of HRP-Decorated Artificial Viral Capsid

The HRP-decorated artificial viral capsids were constructed by incubating solutions of the β-annulus-Ni-NTA peptide with solutions of His-tagged HRP in 10 mM Tris-HCl buffer (pH 7.2) at 25 °C for 24 h. The DLS of the equimolar mixture of β-annulus-Ni-NTA peptide and His-tagged HRP showed average hydrodynamic diameters of approximately 30 nm (Figure 8), which were smaller than those of β-annulus-Ni-NTA peptide assemblies (Figure 3). It is probable that the spherical structures were shrunk by complexation with His-tagged HRP on Ni-NTA-modified artificial viral capsids. TEM images of the aqueous solutions showed the formation of spherical assemblies with diameters of 30–90 nm (Figure 8). To confirm decoration on the exterior of Ni-NTA modified artificial viral capsids by HRP, we measured the ζ-potentials of the Ni-NTA-modified capsid, His-tagged HRP, and their equimolar mixture at pH 7.2 (Figure 9). The ζ-potential of the Ni-NTA-modified capsid was −13.9 ± 5.3 mV, whereas that of the equimolar mixture of Ni-NTA-modified capsid and His-tagged HRP was −21.0 ± 5.8 mV, which is close to that of His-tagged HRP alone, −24.6 ± 4.5 mV. These results indicate that His-tagged HRP was decorated on the exterior of the Ni-NTA-modified artificial viral capsid.
The specific enzyme activity of the HRP-decorated artificial viral capsid was evaluated by colorimetric assay using 4-aminoantipyrine, phenol, and hydrogen peroxide as substrates [46]. The specific enzyme activity of intact His-tagged HRP in potassium phosphate buffer (pH 7.0) at 25 °C was 1.63 Units/mg, whereas that of HRP-decorated artificial viral capsid was 0.238 Units/mg under the same conditions (Figure 10). This decline of HRP activity might be caused by crowding of HRP on the capsid surface and concomitant structural changes. This result is in contrast to the retained activity of RNase S-decorated artificial viral capsids [43].

4. Discussion

We demonstrated that β-annulus peptide bearing Ni-NTA at the C-terminus self-assembled into artificial viral capsids and complexed with recombinant His-tagged HRP. The HRP-decorated artificial viral capsids with sizes of 30–90 nm showed peroxidase activity, but it was lower than that of intact His-tagged HRP. Nolte and coworkers also reported that the activity of HRP-polystyrene assembly was significantly decreased compared to that of intact HRP [23]. Highly dense packing of HRP on the surface of nano-assembly might result in partial thermal denaturation to decrease the activity. However, Morii and coworkers reported a surprising enhancement of activity of dense-packed assembly of carbonic anhydrase on DNA origami scaffolds [47]. They proposed that the entropic force of water increases local substrate or cofactor concentration within the domain confined between enzyme surfaces, thus accelerating the reaction. Thus, we believe that rational design of proper spatial arrangement of enzymes on the surface of an artificial viral capsid will enable the creation of highly active enzyme-decorated capsids.
Compared to artificial protein assemblies previously reported [27,28,29,30,31,32], the strategy presented is simple and general, because it can be constructed from only a 29-residue peptide and easily available His-tagged proteins. Because it can be modified with multiple types of enzymes, the HRP-decorated artificial viral capsids would be applied to a platform for cascade reaction systems such as glucoseoxidase-peroxidase cascade system. Therefore, it can be used to decorate other His-tagged proteins onto artificial viral capsids. We envisage the construction of artificial viral capsids decorated with various proteins, which may be useful as a platform for vaccines and membraneless organelles such as artificial carboxysome.

5. Conclusions

We succeeded in constructing artificial spherical assembly decorated with active HRP via interactions between His-tagged HRP and Ni-NTA-modified β-annulus peptide. The DLS, TEM, and ζ-potential of the assembly revealed the formation of HRP-decorated capsids of 30–90 nm in diameter. Although the peroxidase activity of the assembly was decreased compared to that of intact His-tagged HRP, there is room for improvement of molecular design of enzyme-decorated capsid.

Author Contributions

Conceptualization, K.M.; methodology, T.M. and H.I.; investigation, Y.S. and T.M.; writing, K.M. and H.I.; visualization, Y.S.; supervision, K.M.; funding acquisition, K.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by a Grant-in-Aid for Scientific Research on Innovative Areas “Chemistry for Multimolecular Crowding Biosystems” (grant number: JP18H04558) and a Grant-in-Aid for Scientific Research (B) (grant number: JP18H02089).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Harper, D.R. Viruses: Biology, Applications, and Control, Garland Science, 2nd ed.; Taylor & Francis Group: Oxfordshire, UK, 2012. [Google Scholar]
  2. Mateu, M.G. (Ed.) Structure and Physics of Viruses; Springer: Berlin/Heidelberg, Germany, 2013. [Google Scholar]
  3. Brodsky, F.M. Diversity of clathrin function: New tricks for an old protein. Annu. Rev. Cell Dev. Biol. 2012, 28, 309–336. [Google Scholar] [CrossRef] [PubMed]
  4. Yeates, T.O.; Kerfeld, C.A.; Heinhorst, S.; Cannon, G.C.; Shively, J.M. Protein-based organelles in bacteria: Carboxysomes and related microcompartments. Nat. Rev. Microbiol. 2008, 6, 681–691. [Google Scholar] [CrossRef] [PubMed]
  5. Giessen, T.W.; Silver, P.A. Widespread distribution of encapsulin nanocompartments reveals functional diversity. Nat. Microbiol. 2017, 2, 17029. [Google Scholar] [CrossRef] [PubMed]
  6. Gabashvili, A.N.; Chmelyuk, N.S.; Efremova, M.V.; Malinovskaya, J.A.; Semkina, A.S.; Abakumov, M.A. Encapsulins—Bacterial protein nanocompartments: Structure, properties, and application. Biomolecules 2020, 10, 966. [Google Scholar] [CrossRef]
  7. Azuma, Y.; Edwardson, T.G.W.; Hilvert, D. Tailoring lumazine synthase assemblies for bionanotechnology. Chem. Soc. Rev. 2018, 47, 3543–3557. [Google Scholar] [CrossRef]
  8. Jutz, G.; van Rijn, P.; Miranda, B.S.; Böker, A. Ferritin: A versatile building block for bionanotechnology. Chem. Rev. 2015, 115, 1653–1701. [Google Scholar] [CrossRef]
  9. Ueno, T.; Tabe, H.; Tanaka, Y. Artificial metalloenzymes constructed from hierarchically-assembled proteins. Chem. Asian J. 2013, 8, 1646–1660. [Google Scholar] [CrossRef] [PubMed]
  10. Khudyakov, Y.; Pumpens, P. (Eds.) Viral Nanotechnology; CRC Press: Boca Raton, FL, USA, 2016. [Google Scholar]
  11. Wen, A.M.; Steinmetz, N.F. Design of virus-based nanomaterials for medicine, biotechnology, and energy. Chem. Soc. Rev. 2016, 45, 4074–4126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Van Rijn, P.; Schirhagl, R. Viruses, artificial viruses and virus-based structures for biomedical applications. Adv. Healthcare Mater. 2016, 5, 1386–1400. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Bhaskar, S.; Lim, S. Engineering protein nanocages as carriers for biomedical applications. NPG Asia Mater. 2017, 9, e371. [Google Scholar] [CrossRef]
  14. Ren, H.; Zhu, S.; Zheng, G. Nanoreactor design based on self-assembling protein nanocages. Int. J. Mol. Sci. 2019, 20, 592. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Maity, B.; Fujita, K.; Ueno, T. Use of the confined spaces of apo-ferritin and virus capsids as nanoreactors for catalytic reactions. Curr. Opin. Chem. Biol. 2015, 25, 88–97. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Matsuurua, K. Rational design of self-assembled proteins and peptides for nano- and micro-sized architectures. RSC Adv. 2014, 4, 2942–2953. [Google Scholar] [CrossRef]
  17. De Santis, E.; Ryadnov, M.G. Peptide self-assembly for nanomaterials: The old new kid on the block. Chem. Soc. Rev. 2015, 44, 8288–8300. [Google Scholar] [CrossRef]
  18. Luo, Q.; Hou, C.; Bai, Y.; Wang, R.; Liu, J. Protein assembly: Versatile approaches to construct highly ordered nanostructures. Chem. Rev. 2016, 116, 13571–13632. [Google Scholar] [CrossRef]
  19. Matsuura, K. Synthetic approaches to construct viral capsid-like spherical nanomaterials. Chem. Commun. 2018, 54, 8944–8959. [Google Scholar] [CrossRef]
  20. Kuan, S.L.; Bergamini, F.R.G.; Weil, T. Functional protein nanostructures: A chemical toolbox. Chem. Soc. Rev. 2018, 47, 9069–9105. [Google Scholar] [CrossRef] [Green Version]
  21. Lou, S.; Wang, X.; Yu, Z.; Shi, L. Peptide tectonics: Encoded structural complementarity dictates programmable self-assembly. Adv. Sci. 2019, 6, 1802043. [Google Scholar] [CrossRef] [Green Version]
  22. Hamley, I.W. Protein assemblies: Nature-inspired and designed nanostructures. Biomacromolecules 2019, 20, 1829–1848. [Google Scholar] [CrossRef] [Green Version]
  23. Boerakker, M.J.; Hannink, J.M.; Bomans, P.H.H.; Frederik, P.M.; Nolte, R.J.M.; Meijer, E.M.; Sommerdijk, N.A.J.M. Giant amphiphiles by cofactor reconstitution. Angew. Chem. Int. Ed. 2002, 41, 4239–4241. [Google Scholar] [CrossRef]
  24. Reynhout, I.C.; Cornelissen, J.J.L.M.; Nolte, R.J.M. Self-assembled architectures from biohybrid triblock copolymers. J. Am. Chem. Soc. 2007, 129, 2327–2332. [Google Scholar] [CrossRef] [PubMed]
  25. Delaittre, G.; Reynhout, I.C.; Cornelissen, J.J.L.M.; Nolte, R.J.M. Cascade reactions in an all-enzyme nanoreactor. Chem. Eur. J. 2009, 15, 12600–12603. [Google Scholar] [CrossRef] [PubMed]
  26. Hirayama, S.; Oohora, K.; Uchihashi, T.; Hayashi, T. Thermoresponsive micellar assembly constructed from a hexameric hemoprotein modified with poly(N-isopropylacrylamide) toward an artificial light-harvesting system. J. Am. Chem. Soc. 2020, 142, 1822–1831. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Fletcher, J.M.; Harniman, R.L.; Barnes, F.R.H.; Boyle, A.L.; Collins, A.; Mantell, J.; Sharp, T.H.; Antognozzi, M.; Booth, P.J.; Linden, N.; et al. Self-assembling cages from coiled-coil peptide modules. Science 2013, 340, 595–599. [Google Scholar] [CrossRef]
  28. Ross, J.F.; Bridges, A.; Fletcher, J.M.; Shoemark, D.; Alibhai, D.; Bray, H.E.V.; Beesley, J.L.; Dawson, W.M.; Hodgson, L.R.; Mantell, J.; et al. Decorating self-assembled peptide cages with proteins. ACS Nano 2017, 11, 7901–7914. [Google Scholar] [CrossRef]
  29. Kawakami, N.; Kondo, H.; Matsuzawa, Y.; Hayasaka, K.; Nasu, E.; Sasahara, K.; Arai, R.; Miyamoto, K. Design of hollow protein nanoparticles with modifiable interior and exterior surfaces. Angew. Chem. Int. Ed. 2018, 57, 12400–12404. [Google Scholar] [CrossRef]
  30. Cristie-David, A.S.; Chen, J.; Nowak, D.B.; Bondy, A.L.; Sun, K.; Park, S.I.; Holl, M.M.B.; Su, M.; Marsh, E.N.G. Coiled-coil-mediated assembly of an icosahedral protein cage with extremely high thermal and chemical stability. J. Am. Chem. Soc. 2019, 141, 9207–9216. [Google Scholar] [CrossRef]
  31. De Santis, E.; Alkassem, H.; Lamarre, B.; Faruqui, N.; Bella, A.; Noble, J.E.; Micale, N.; Ray, S.; Burns, J.R.; Yon, A.R.; et al. Antimicrobial peptide capsids of de novo design. Nat. Commun. 2017, 8, 2263. [Google Scholar] [CrossRef] [Green Version]
  32. Kepiro, I.E.; Marzuoli, I.; Hammond, K.; Ba, X.; Lewis, H.; Shaw, M.; Gunnoo, S.B.; De Santis, E.; Łapińska, U.; Pagliara, S.; et al. Engineering chirally blind protein pseudocapsids into antibacterial persisters. ACS Nano 2020, 14, 1609–1622. [Google Scholar] [CrossRef]
  33. Matsuura, K.; Watanabe, K.; Sakurai, K.; Matsuzaki, T.; Kimizuka, N. Self-assembled synthetic viral capsids from a 24-mer viral peptide fragment. Angew. Chem. Int. Ed. 2010, 49, 9662–9665. [Google Scholar] [CrossRef]
  34. Matsuura, K.; Watanabe, K.; Matsushita, Y.; Kimizuka, N. Guest-binding behavior of peptide nanocapsules self-assembled from viral peptide fragments. Polymer J. 2013, 45, 529–534. [Google Scholar] [CrossRef] [Green Version]
  35. Nakamura, Y.; Inaba, H.; Matsuura, K. Construction of artificial viral capsids encapsulating short DNAs via disulfide bonds and controlled release of DNAs by reduction. Chem. Lett. 2019, 48, 544–546. [Google Scholar] [CrossRef]
  36. Fujita, S.; Matsuura, K. Inclusion of zinc oxide nanoparticles into virus-like peptide nanocapsules self-assembled from viral β-annulus peptide. Nanomaterials 2014, 4, 778–791. [Google Scholar] [CrossRef] [PubMed]
  37. Fujita, S.; Matsuura, K. Encapsulation of CdTe quantum dots into synthetic viral capsids. Chem. Lett. 2016, 45, 922–924. [Google Scholar] [CrossRef] [Green Version]
  38. Matsuura, K.; Nakamura, T.; Watanabe, K.; Noguchi, T.; Minamihata, K.; Kamiya, N.; Kimizuka, N. Self-assembly of Ni-NTA-modified β-annulus peptides into artificial viral capsids and encapsulation of His-tagged proteins. Org. Biomol. Chem. 2016, 14, 7869–7874. [Google Scholar] [CrossRef] [Green Version]
  39. Matsuura, K.; Ueno, G.; Fujita, S. Self-assembled artificial viral capsid decorated with gold nanoparticles. Polymer J. 2015, 47, 146–151. [Google Scholar] [CrossRef] [Green Version]
  40. Fujita, S.; Matsuura, K. Self-assembled artificial viral capsids bearing coiled-coils at the surface. Org. Biomol. Chem. 2017, 15, 5070–5077. [Google Scholar] [CrossRef] [Green Version]
  41. Nakamura, Y.; Yamada, S.; Nishikawa, S.; Matsuura, K. DNA-modified artificial viral capsids self-assembled from DNA-conjugated β-annulus peptide. J. Pept. Sci. 2017, 23, 636–643. [Google Scholar] [CrossRef] [Green Version]
  42. Matsuura, K.; Honjo, T. Artificial viral capsid dressed up with human serum albumin. Bioconj. Chem. 2019, 30, 1636–1641. [Google Scholar] [CrossRef]
  43. Matsuura, K.; Ota, J.; Fujita, S.; Shiomi, Y.; Inaba, H. Construction of ribonuclease-decorated artificial virus-like capsid by peptide self-assembly. J. Org. Chem. 2020, 85, 1668–1673. [Google Scholar] [CrossRef] [Green Version]
  44. Matsuura, K. Dressing up artificial viral capsids self-assembled from C-terminal-modified β-annulus peptides. Polymer J. 2020, 52, 1035–1041. [Google Scholar] [CrossRef]
  45. Grigorenko, V.; Chuber, T.; Kapeliuch, Y.; Borchers, T.; Spener, F.; Egorov, A. New approaches for functional expression of recombinant horseradish peroxidase C in Escherichia coli. Biocatal. Biotransfor. 1999, 17, 359–379. [Google Scholar] [CrossRef]
  46. Nicell, J.A.; Wright, H. A model of peroxidase activity with inhibition by hydrogen peroxide. Enzym. Microb. Technol. 1997, 21, 302–310. [Google Scholar] [CrossRef]
  47. Dinh, H.; Nakata, E.; Mutsuda-Zapater, K.; Saimura, M.; Kinoshita, M.; Morii, T. Enhanced enzymatic activity exerted by a packed assembly of a single type of enzyme. Chem. Sci. 2020, 11, 9088–9100. [Google Scholar] [CrossRef]
Processes 08 01455 g001 550
Figure 1. The self-assembly of artificial viral capsids decorated with Ni-NTA and horseradish peroxidase (HRP).
Figure 1. The self-assembly of artificial viral capsids decorated with Ni-NTA and horseradish peroxidase (HRP).
Processes 08 01455 g001
Processes 08 01455 g002 550
Figure 2. Structure and amino acid sequence of His-tagged HRP.
Figure 2. Structure and amino acid sequence of His-tagged HRP.
Processes 08 01455 g002
Processes 08 01455 g003 550
Figure 3. Size distributions obtained from Dynamic Light Scattering (DLS) at 25 °C and transmission electron microscopy (TEM) images for solutions of (a) 25 μM and (b) 50 μM β-annulus peptide modified with Ni-NTA at the C-terminus in a 10 mM Tris-HCl buffer (pH 7.2).
Figure 3. Size distributions obtained from Dynamic Light Scattering (DLS) at 25 °C and transmission electron microscopy (TEM) images for solutions of (a) 25 μM and (b) 50 μM β-annulus peptide modified with Ni-NTA at the C-terminus in a 10 mM Tris-HCl buffer (pH 7.2).
Processes 08 01455 g003
Processes 08 01455 g004 550
Figure 4. Effect of the concentration of β-annulus peptide modified with Ni-NTA on scattering intensity determined by DLS at 25 °C in a 10 mM Tris-HCl buffer (pH 7.2).
Figure 4. Effect of the concentration of β-annulus peptide modified with Ni-NTA on scattering intensity determined by DLS at 25 °C in a 10 mM Tris-HCl buffer (pH 7.2).
Processes 08 01455 g004
Processes 08 01455 g005 550
Figure 5. Schematic illustration of the preparation of His-tagged HRP.
Figure 5. Schematic illustration of the preparation of His-tagged HRP.
Processes 08 01455 g005
Processes 08 01455 g006 550
Figure 6. (a) SDS-PAGE of His-tagged apo-HRP (Lane 2: 0.4 mg/mL, Lane 3: 0.2 mg/mL) and (b) MALDI-TOF-MS of His-tagged HRP.
Figure 6. (a) SDS-PAGE of His-tagged apo-HRP (Lane 2: 0.4 mg/mL, Lane 3: 0.2 mg/mL) and (b) MALDI-TOF-MS of His-tagged HRP.
Processes 08 01455 g006
Processes 08 01455 g007 550
Figure 7. UV-Vis spectra of (a) hemin (24 mM), (b) His-tagged HRP (0.2 mg/mL), and (c) commercially available HRP (0.2 mg/mL) in 10 mM Tris-HCl buffer (pH 7.2).
Figure 7. UV-Vis spectra of (a) hemin (24 mM), (b) His-tagged HRP (0.2 mg/mL), and (c) commercially available HRP (0.2 mg/mL) in 10 mM Tris-HCl buffer (pH 7.2).
Processes 08 01455 g007
Processes 08 01455 g008 550
Figure 8. Size distributions obtained from DLS at 25 °C and TEM images for solutions of (a) 50 μM Ni-NTA modified β-annulus peptide and 50 μM His-tagged HRP, (b) 25 μM Ni-NTA modified β-annulus peptide and 25 μM His-tagged HRP in 10 mM Tris-HCl buffer (pH 7.2).
Figure 8. Size distributions obtained from DLS at 25 °C and TEM images for solutions of (a) 50 μM Ni-NTA modified β-annulus peptide and 50 μM His-tagged HRP, (b) 25 μM Ni-NTA modified β-annulus peptide and 25 μM His-tagged HRP in 10 mM Tris-HCl buffer (pH 7.2).
Processes 08 01455 g008
Processes 08 01455 g009 550
Figure 9. ζ-Potentials of (a) the assembly of 25 μM Ni-NTA modified β-annulus peptide, (b) 25 μM His-tagged HRP, and (c) their 1:1 mixture in 10 mM Tris-HCl buffer (pH 7.2).
Figure 9. ζ-Potentials of (a) the assembly of 25 μM Ni-NTA modified β-annulus peptide, (b) 25 μM His-tagged HRP, and (c) their 1:1 mixture in 10 mM Tris-HCl buffer (pH 7.2).
Processes 08 01455 g009
Processes 08 01455 g010 550
Figure 10. Time courses of absorbance increase at 510 nm due to the enzymatic reaction of (a) His-tagged HRP (11.4 μM) and (b) HRP-decorated artificial viral capsid (25 μM) using 4-aminoantipyrine, phenol, and hydrogen peroxide as substrates in the phosphate buffer (pH 7.0) at 25 °C.
Figure 10. Time courses of absorbance increase at 510 nm due to the enzymatic reaction of (a) His-tagged HRP (11.4 μM) and (b) HRP-decorated artificial viral capsid (25 μM) using 4-aminoantipyrine, phenol, and hydrogen peroxide as substrates in the phosphate buffer (pH 7.0) at 25 °C.
Processes 08 01455 g010
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Matsuura, K.; Shiomi, Y.; Mizuta, T.; Inaba, H. Horseradish Peroxidase-Decorated Artificial Viral Capsid Constructed from β-Annulus Peptide via Interaction between His-Tag and Ni-NTA. Processes 2020, 8, 1455. https://doi.org/10.3390/pr8111455

AMA Style

Matsuura K, Shiomi Y, Mizuta T, Inaba H. Horseradish Peroxidase-Decorated Artificial Viral Capsid Constructed from β-Annulus Peptide via Interaction between His-Tag and Ni-NTA. Processes. 2020; 8(11):1455. https://doi.org/10.3390/pr8111455

Chicago/Turabian Style

Matsuura, Kazunori, Yuriko Shiomi, Toshihumi Mizuta, and Hiroshi Inaba. 2020. "Horseradish Peroxidase-Decorated Artificial Viral Capsid Constructed from β-Annulus Peptide via Interaction between His-Tag and Ni-NTA" Processes 8, no. 11: 1455. https://doi.org/10.3390/pr8111455

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop